| Historic (1865-12-01 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Paclitaxel
|
25 |
349.4 |
  |
| 2 |
paclitaxel
|
15 |
204.1 |
  |
| 3 |
Taxol
|
12 |
168.5 |
  |
| 4 |
15 min
|
8 |
113.6 |
  |
| 5 |
Cremophor-free
|
4 |
56.8 |
  |
| 6 |
PURPOSE
|
4 |
50.6 |
  |
| 7 |
CONCLUSIONS
|
4 |
47.3 |
  |
| 8 |
Cremophor EL-formulated
|
2 |
28.4 |
  |
| 9 |
Cremophor
|
2 |
27.0 |
  |
| 10 |
SD
|
2 |
27.0 |
  |
| 11 |
deep peripheral compartment
|
2 |
27.0 |
  |
| 12 |
neutropenia
|
2 |
26.2 |
  |
| 13 |
target
|
2 |
25.2 |
  |
| 14 |
cancer
|
2 |
22.9 |
  |
| 15 |
METHODS
|
2 |
22.8 |
  |
|
| 10 years (1999-12-23 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Paclitaxel
|
25 |
329.7 |
  |
| 2 |
paclitaxel
|
15 |
192.3 |
  |
| 3 |
Taxol
|
12 |
159.1 |
  |
| 4 |
15 min
|
8 |
107.3 |
  |
| 5 |
Cremophor-free
|
4 |
53.7 |
  |
| 6 |
PURPOSE
|
4 |
47.4 |
  |
| 7 |
CONCLUSIONS
|
4 |
44.2 |
  |
| 8 |
Cremophor EL-formulated
|
2 |
26.8 |
  |
| 9 |
Cremophor
|
2 |
25.4 |
  |
| 10 |
SD
|
2 |
25.4 |
  |
| 11 |
deep peripheral compartment
|
2 |
25.4 |
  |
| 12 |
neutropenia
|
2 |
24.6 |
  |
| 13 |
target
|
2 |
23.6 |
  |
| 14 |
cancer
|
2 |
21.3 |
  |
| 15 |
METHODS
|
2 |
21.2 |
  |
|
| 365 days (2008-12-20 to
2009-12-20) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
Paclitaxel
|
24 |
245.3 |
  |
| 2 |
paclitaxel
|
14 |
138.2 |
  |
| 3 |
Taxol
|
12 |
123.1 |
  |
| 4 |
15 min
|
8 |
83.3 |
  |
| 5 |
Cremophor-free
|
4 |
41.6 |
  |
| 6 |
PURPOSE
|
4 |
35.4 |
  |
| 7 |
CONCLUSIONS
|
4 |
32.1 |
  |
| 8 |
Cremophor EL-formulated
|
2 |
20.8 |
  |
| 9 |
Cremophor
|
2 |
19.4 |
  |
| 10 |
SD
|
2 |
19.4 |
  |
| 11 |
deep peripheral compartment
|
2 |
19.4 |
  |
| 12 |
neutropenia
|
2 |
18.6 |
  |
| 13 |
target
|
2 |
17.6 |
  |
| 14 |
cancer
|
2 |
15.3 |
  |
| 15 |
METHODS
|
2 |
15.2 |
  |
|